| Product Code: ETC7916544 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Neuropathic Pain Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Neuropathic Pain Market Revenues & Volume, 2021 & 2031F |
3.3 Latvia Neuropathic Pain Market - Industry Life Cycle |
3.4 Latvia Neuropathic Pain Market - Porter's Five Forces |
3.5 Latvia Neuropathic Pain Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Latvia Neuropathic Pain Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Latvia Neuropathic Pain Market Revenues & Volume Share, By Procedure, 2021 & 2031F |
3.8 Latvia Neuropathic Pain Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.9 Latvia Neuropathic Pain Market Revenues & Volume Share, By Modality, 2021 & 2031F |
3.10 Latvia Neuropathic Pain Market Revenues & Volume Share, By Mode of Purchase, 2021 & 2031F |
3.11 Latvia Neuropathic Pain Market Revenues & Volume Share, By Pain Type, 2021 & 2031F |
4 Latvia Neuropathic Pain Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Aging population leading to higher prevalence of neuropathic pain |
4.2.2 Increasing awareness and diagnosis of neuropathic pain conditions |
4.2.3 Rising adoption of advanced treatment options and technologies |
4.3 Market Restraints |
4.3.1 Limited access to specialized healthcare services in certain regions |
4.3.2 High cost associated with neuropathic pain treatment |
4.3.3 Lack of reimbursement policies for neuropathic pain medications |
5 Latvia Neuropathic Pain Market Trends |
6 Latvia Neuropathic Pain Market, By Types |
6.1 Latvia Neuropathic Pain Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Latvia Neuropathic Pain Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Latvia Neuropathic Pain Market Revenues & Volume, By Spinal Cord Stimulation (SCS) Devices, 2021- 2031F |
6.1.4 Latvia Neuropathic Pain Market Revenues & Volume, By External Peripheral Nerve Stimulation, 2021- 2031F |
6.1.5 Latvia Neuropathic Pain Market Revenues & Volume, By Transcutaneous Electrical Nerve Stimulation (Tens) Devices, 2021- 2031F |
6.2 Latvia Neuropathic Pain Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 Latvia Neuropathic Pain Market Revenues & Volume, By Rechargeable and Non-Rechargeable, 2021- 2031F |
6.3 Latvia Neuropathic Pain Market, By Procedure |
6.3.1 Overview and Analysis |
6.3.2 Latvia Neuropathic Pain Market Revenues & Volume, By Invasive and Non-Invasive, 2021- 2031F |
6.4 Latvia Neuropathic Pain Market, By Technology |
6.4.1 Overview and Analysis |
6.4.2 Latvia Neuropathic Pain Market Revenues & Volume, By Transcutaneous Electrical Nerve Stimulation, 2021- 2031F |
6.4.3 Latvia Neuropathic Pain Market Revenues & Volume, By Transcranial Magnetic Stimulation, 2021- 2031F |
6.4.4 Latvia Neuropathic Pain Market Revenues & Volume, By Respiratory Electrical Stimulation, 2021- 2031F |
6.5 Latvia Neuropathic Pain Market, By Modality |
6.5.1 Overview and Analysis |
6.5.2 Latvia Neuropathic Pain Market Revenues & Volume, By Stationary, 2021- 2031F |
6.5.3 Latvia Neuropathic Pain Market Revenues & Volume, By Portable, 2021- 2031F |
6.6 Latvia Neuropathic Pain Market, By Mode of Purchase |
6.6.1 Overview and Analysis |
6.6.2 Latvia Neuropathic Pain Market Revenues & Volume, By Over-the-Counter Devices, 2021- 2031F |
6.6.3 Latvia Neuropathic Pain Market Revenues & Volume, By Prescription-Based Devices, 2021- 2031F |
6.7 Latvia Neuropathic Pain Market, By Pain Type |
6.7.1 Overview and Analysis |
6.7.2 Latvia Neuropathic Pain Market Revenues & Volume, By Peripheral Neuropathy, 2021- 2031F |
6.7.3 Latvia Neuropathic Pain Market Revenues & Volume, By Entrapment Neuropathy, 2021- 2031F |
6.7.4 Latvia Neuropathic Pain Market Revenues & Volume, By Trigeminal Neuralgia, 2021- 2031F |
6.7.5 Latvia Neuropathic Pain Market Revenues & Volume, By Trigeminal Neuralgia, 2021- 2031F |
6.7.6 Latvia Neuropathic Pain Market Revenues & Volume, By Post Herpetic Neuralgia (PHN), 2021- 2031F |
6.7.7 Latvia Neuropathic Pain Market Revenues & Volume, By Post Traumatic Neuropathy, 2021- 2031F |
6.7.8 Latvia Neuropathic Pain Market Revenues & Volume, By Coccydynia, 2021- 2031F |
6.7.9 Latvia Neuropathic Pain Market Revenues & Volume, By Coccydynia, 2021- 2031F |
6.8 Latvia Neuropathic Pain Market, By Indication |
6.8.1 Overview and Analysis |
6.8.2 Latvia Neuropathic Pain Market Revenues & Volume, By Spinal Stenosis, 2021- 2031F |
6.8.3 Latvia Neuropathic Pain Market Revenues & Volume, By Chemotherapy-Induced Peripheral Neuropathy, 2021- 2031F |
6.8.4 Latvia Neuropathic Pain Market Revenues & Volume, By Others, 2021- 2031F |
6.8.5 Latvia Neuropathic Pain Market Revenues & Volume, By Others, 2021- 2031F |
7 Latvia Neuropathic Pain Market Import-Export Trade Statistics |
7.1 Latvia Neuropathic Pain Market Export to Major Countries |
7.2 Latvia Neuropathic Pain Market Imports from Major Countries |
8 Latvia Neuropathic Pain Market Key Performance Indicators |
8.1 Number of healthcare facilities offering specialized neuropathic pain treatment |
8.2 Percentage of healthcare professionals trained in diagnosing and managing neuropathic pain |
8.3 Patient satisfaction with neuropathic pain management services |
8.4 Adoption rate of new neuropathic pain treatment modalities |
8.5 Average wait time for patients seeking neuropathic pain treatment |
9 Latvia Neuropathic Pain Market - Opportunity Assessment |
9.1 Latvia Neuropathic Pain Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Latvia Neuropathic Pain Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 Latvia Neuropathic Pain Market Opportunity Assessment, By Procedure, 2021 & 2031F |
9.4 Latvia Neuropathic Pain Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.5 Latvia Neuropathic Pain Market Opportunity Assessment, By Modality, 2021 & 2031F |
9.6 Latvia Neuropathic Pain Market Opportunity Assessment, By Mode of Purchase, 2021 & 2031F |
9.7 Latvia Neuropathic Pain Market Opportunity Assessment, By Pain Type, 2021 & 2031F |
9.7 Latvia Neuropathic Pain Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 Latvia Neuropathic Pain Market - Competitive Landscape |
10.1 Latvia Neuropathic Pain Market Revenue Share, By Companies, 2024 |
10.2 Latvia Neuropathic Pain Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here